407 related articles for article (PubMed ID: 28257634)
1. Structural basis for potency differences between GDF8 and GDF11.
Walker RG; Czepnik M; Goebel EJ; McCoy JC; Vujic A; Cho M; Oh J; Aykul S; Walton KL; Schang G; Bernard DJ; Hinck AP; Harrison CA; Martinez-Hackert E; Wagers AJ; Lee RT; Thompson TB
BMC Biol; 2017 Mar; 15(1):19. PubMed ID: 28257634
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.
McCoy JC; Walker RG; Murray NH; Thompson TB
J Biol Chem; 2019 Apr; 294(16):6333-6343. PubMed ID: 30814254
[TBL] [Abstract][Full Text] [Related]
3. Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.
Walker RG; Poggioli T; Katsimpardi L; Buchanan SM; Oh J; Wattrus S; Heidecker B; Fong YW; Rubin LL; Ganz P; Thompson TB; Wagers AJ; Lee RT
Circ Res; 2016 Apr; 118(7):1125-41; discussion 1142. PubMed ID: 27034275
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of human GDF11.
Padyana AK; Vaidialingam B; Hayes DB; Gupta P; Franti M; Farrow NA
Acta Crystallogr F Struct Biol Commun; 2016 Mar; 72(Pt 3):160-4. PubMed ID: 26919518
[TBL] [Abstract][Full Text] [Related]
5. Functional substitutions of amino acids that differ between GDF11 and GDF8 impact skeletal development and skeletal muscle.
Lian J; Walker RG; D'Amico A; Vujic A; Mills MJ; Messemer KA; Mendello KR; Goldstein JM; Leacock KA; Epp S; Stimpfl EV; Thompson TB; Wagers AJ; Lee RT
Life Sci Alliance; 2023 Mar; 6(3):. PubMed ID: 36631218
[TBL] [Abstract][Full Text] [Related]
6. Differential Binding Activity of TGF-β Family Proteins to Select TGF-β Receptors.
Khalil AM; Dotimas H; Kahn J; Lamerdin JE; Hayes DB; Gupta P; Franti M
J Pharmacol Exp Ther; 2016 Sep; 358(3):423-30. PubMed ID: 27340210
[TBL] [Abstract][Full Text] [Related]
7. Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2.
Lee YS; Lee SJ
Proc Natl Acad Sci U S A; 2013 Sep; 110(39):E3713-22. PubMed ID: 24019467
[TBL] [Abstract][Full Text] [Related]
8. Interaction with the GDF8/11 pathway reveals treatment options for adenocarcinoma of the breast.
Wallner C; Drysch M; Becerikli M; Jaurich H; Wagner JM; Dittfeld S; Nagler J; Harati K; Dadras M; Philippou S; Lehnhardt M; Behr B
Breast; 2018 Feb; 37():134-141. PubMed ID: 29156385
[TBL] [Abstract][Full Text] [Related]
9. GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.
Suh J; Kim NK; Lee SH; Eom JH; Lee Y; Park JC; Woo KM; Baek JH; Kim JE; Ryoo HM; Lee SJ; Lee YS
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4910-4920. PubMed ID: 32071240
[TBL] [Abstract][Full Text] [Related]
10. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
[TBL] [Abstract][Full Text] [Related]
11. Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease.
Schafer MJ; Atkinson EJ; Vanderboom PM; Kotajarvi B; White TA; Moore MM; Bruce CJ; Greason KL; Suri RM; Khosla S; Miller JD; Bergen HR; LeBrasseur NK
Cell Metab; 2016 Jun; 23(6):1207-1215. PubMed ID: 27304512
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor 8 induces SKOV3 ovarian cancer cell migration and E-cadherin down-regulation.
Zhao J; Klausen C; Xiong S; Cheng JC; Chang HM; Leung PC
Cell Signal; 2016 Nov; 28(11):1615-22. PubMed ID: 27481097
[TBL] [Abstract][Full Text] [Related]
13. Relationship of Circulating Growth and Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry With Age and Skeletal Muscle Strength in Healthy Adults.
Semba RD; Zhang P; Zhu M; Fabbri E; Gonzalez-Freire M; Carlson OD; Moaddel R; Tanaka T; Egan JM; Ferrucci L
J Gerontol A Biol Sci Med Sci; 2019 Jan; 74(1):129-136. PubMed ID: 30380014
[TBL] [Abstract][Full Text] [Related]
14. Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin.
Schneyer AL; Sidis Y; Gulati A; Sun JL; Keutmann H; Krasney PA
Endocrinology; 2008 Sep; 149(9):4589-95. PubMed ID: 18535106
[TBL] [Abstract][Full Text] [Related]
15. Reduced Circulating GDF11 Is Unlikely Responsible for Age-Dependent Changes in Mouse Heart, Muscle, and Brain.
Rodgers BD; Eldridge JA
Endocrinology; 2015 Nov; 156(11):3885-8. PubMed ID: 26372181
[TBL] [Abstract][Full Text] [Related]
16. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration.
Egerman MA; Cadena SM; Gilbert JA; Meyer A; Nelson HN; Swalley SE; Mallozzi C; Jacobi C; Jennings LL; Clay I; Laurent G; Ma S; Brachat S; Lach-Trifilieff E; Shavlakadze T; Trendelenburg AU; Brack AS; Glass DJ
Cell Metab; 2015 Jul; 22(1):164-74. PubMed ID: 26001423
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of latent GDF8 reveals mechanisms of activation.
Walker RG; McCoy JC; Czepnik M; Mills MJ; Hagg A; Walton KL; Cotton TR; Hyvönen M; Lee RT; Gregorevic P; Harrison CA; Thompson TB
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):E866-E875. PubMed ID: 29348202
[TBL] [Abstract][Full Text] [Related]
18. Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration.
Rochette L; Zeller M; Cottin Y; Vergely C
Pharmacol Ther; 2015 Dec; 156():26-33. PubMed ID: 26523637
[TBL] [Abstract][Full Text] [Related]
19. The Growth Differentiation Factor 11 (GDF11) and Myostatin (MSTN) in tissue specific aging.
Fan X; Gaur U; Sun L; Yang D; Yang M
Mech Ageing Dev; 2017 Jun; 164():108-112. PubMed ID: 28472635
[TBL] [Abstract][Full Text] [Related]
20. Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11.
Kondás K; Szláma G; Trexler M; Patthy L
J Biol Chem; 2008 Aug; 283(35):23677-84. PubMed ID: 18596030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
